Werewolf Therapeutics Stock Options
| HOWL Stock | USD 1.42 0.02 1.43% |
Werewolf Therapeutics' latest option contracts expiring on October 17th 2025 are carrying combined implied volatility of 4.36 with a put-to-call open interest ratio of 0.01 over 6 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on October 17th 2025.
Open Interest Against October 17th 2025 Option Contracts
2025-10-17
The chart above shows Werewolf Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Werewolf Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Werewolf Therapeutics' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Werewolf Therapeutics
Analyzing Werewolf Therapeutics' in-the-money options over time can help investors to take a profitable long position in Werewolf Therapeutics regardless of its overall volatility. This is especially true when Werewolf Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Werewolf Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Werewolf Therapeutics' stock while costing only a fraction of its price.
Werewolf Current Options Market Mood
Werewolf Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Werewolf Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Werewolf Therapeutics' options investors are not very successful. Werewolf Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Werewolf contract
Base on the Rule 16, the options market is currently suggesting that Werewolf Therapeutics will have an average daily up or down price movement of about 0.27% per day over the life of the 2025-10-17 option contract. With Werewolf Therapeutics trading at USD 1.42, that is roughly USD 0.00387. If you think that the market is fully incorporating Werewolf Therapeutics' daily price movement you should consider buying Werewolf Therapeutics options at the current volatility level of 4.36%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Werewolf Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Werewolf calls. Remember, the seller must deliver Werewolf Therapeutics stock to the call owner when a call is exercised.
Werewolf Therapeutics Option Chain
When Werewolf Therapeutics' strike price is surpassing the current stock price, the option contract against Werewolf Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Werewolf Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Werewolf. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Werewolf. It also shows strike prices and maturity days for a Werewolf Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | HOWL251017C00007500 | 0 | 7.5 | 0.0 - 2.35 | 2.35 | |
Call | HOWL251017C00005000 | 0 | 5.0 | 0.0 - 2.35 | 2.35 | |
Call | HOWL251017C00002500 | 774 | 2.5 | 0.05 - 0.2 | 0.15 | Out |
Put | HOWL251017P00007500 | 8 | 7.5 | 4.8 - 6.9 | 6.4 | In |
Put | HOWL251017P00005000 | 0 | 5.0 | 2.8 - 4.2 | 2.8 | In |
Put | HOWL251017P00002500 | 0 | 2.5 | 0.0 - 2.35 | 2.35 | In |
Werewolf Total Stockholder Equity
Total Stockholder Equity |
|
Werewolf Therapeutics Corporate Management
| Randi MD | Chief Officer | Profile | |
| Timothy CPA | Treasurer CFO | Profile | |
| Cynthia SeidelDugan | Chief Officer | Profile | |
| Ellen MBA | Chief Officer | Profile | |
| Daniel Hicklin | CEO, Founder | Profile | |
| William Winston | Senior Research | Profile | |
| Chulani Karunatilake | Chief Officer | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Werewolf Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For more information on how to buy Werewolf Stock please use our How to buy in Werewolf Stock guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Werewolf Therapeutics. If investors know Werewolf will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Werewolf Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.64) | Revenue Per Share | Quarterly Revenue Growth (1.00) | Return On Assets | Return On Equity |
The market value of Werewolf Therapeutics is measured differently than its book value, which is the value of Werewolf that is recorded on the company's balance sheet. Investors also form their own opinion of Werewolf Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Werewolf Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Werewolf Therapeutics' market value can be influenced by many factors that don't directly affect Werewolf Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Werewolf Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Werewolf Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Werewolf Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.